Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression

The American Journal of Medicine
John J P KasteleinRaaj Sankatsing

Abstract

Changes in intima-media thickness (IMT) and arterial lumen diameter-as measured by B-mode high-resolution ultrasonography and quantitative coronary angiography, respectively-are currently the only surrogate markers for progression of atherosclerotic disease recognized by regulatory authorities in the United States and Europe. Because atherosclerosis is a disease of the arterial wall, the ability of B-mode ultrasonography to provide visualization of IMT offers significant advantages over angiography. These advantages, as well as the safety and noninvasiveness of B-mode ultrasonography, have led to increasing use of this imaging technique in observational studies and interventional studies of lipid-lowering agents over the last decade. These observational studies clearly demonstrated an association between carotid IMT and atherosclerotic disease. Of the interventional studies, the recent Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) trial found that use of atorvastatin 80 mg daily for aggressive lowering of plasma low-density lipoprotein cholesterol (LDL-C) concentrations to below current target levels was associated with significant IMT regression compared with results obtained...Continue Reading

References

Feb 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D H Blankenhorn, H N Hodis
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Mar 7, 2002·The American Journal of Cardiology·Donald M Black
Sep 25, 2002·Drugs·Christopher I CarswellBlair Jarvis
Jul 16, 2003·The American Journal of Cardiology·Peter H JonesUNKNOWN STELLAR Study Group

❮ Previous
Next ❯

Citations

Mar 15, 2012·Medical & Biological Engineering & Computing·Rui RochaAurélio Campilho
Apr 2, 2005·Nature Reviews. Neuroscience·Til MengeOlaf Stüve
Jul 2, 2005·Current Opinion in Lipidology·Raaj R SankatsingJohn J P Kastelein
Nov 13, 2007·Current Opinion in Lipidology·Raphael DuivenvoordenJohn J P Kastelein
May 30, 2009·Vascular Health and Risk Management·Naila Goldenberg, Charles Glueck
Jun 25, 2014·BMC Infectious Diseases·Paula FreitasJosé Luís Medina
Feb 24, 2016·Data in Brief·Michael H DavidsonAndrew M Tershakovec
Jan 17, 2016·Atherosclerosis·Michael H DavidsonAndrew M Tershakovec
May 19, 2010·Computer Methods and Programs in Biomedicine·Filippo MolinariJasjit S Suri
Mar 19, 2011·Progress in Cardiovascular Diseases·Nino KünzliBarbara Hoffmann
Mar 15, 2011·Medicina clínica·Antonio Luis Aguilar-SheaJosé Luis Zamorano
Apr 25, 2007·Vascular Medicine·Eric R BatesUNKNOWN Society for Interventional Radiology
Jul 9, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Raaj R SankatsingErik S G Stroes
Nov 6, 2004·Current Opinion in Lipidology·W A van der SteegJ J P Kastelein
Jul 17, 2009·The Open Cardiovascular Medicine Journal·Armen Yuri Gasparyan
Jan 16, 2015·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Aart C StrangFrieke M A Box
Feb 3, 2007·Pediatrics·Brook BelayCatherine Tom-Revzon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.